ARCHIVES

Center Review By Panel, NCI Leading To Changes; Hammer Tells NCAB It Faces “Difficult Decision”

This article is from The Cancer Letter archive.

Vol. 10 No. 48 | December 13, 1984

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer An Alteration In Gene Expression, Not Change In Structure, Tulane Biologist Reports

March 27, 1981

Brown Disagrees With Staff, Subgroup On Dichlorvos, Says It Is a Carcinogen

September 2, 1977

NCI To Test 5,000 DC-Area Jews To Determine Risk Of BRCA 1 Mutation

October 6, 1995

Jako Bows Out with Blast At NCI, Calls For IOM Review Of Cancer Program

April 15, 1988

This month’s 8-page Business & Regulatory Report included in this issue.

January 30, 2004

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001